1、肝 癌的诊治进展5-y: 12%-25% 5-y: 5%-15%HCC的危险因素及进展肝癌基因组中体细胞基因获得性改变的全基因组模式图Tateishi R % Omata M. Nat Rev Gastroenterol Hepatol 2012; 9:69-70Normal Inflammation CirrhosisDuctular reactionsDysplasiaHCC in cirrhotic backgroundHCC in non-cirrhotic backgroundHCC癌变过程中病理组织学改变Ramakrishna G, et al. Liver Cancer 2013
2、; 2: 367-383微小肝癌至大肝癌的生长类型Cong WM, Wu MC. Hepatol Int 2013; 7: 805-812HCC癌变过程中肝组织细胞学改变Ramakrishna G, et al. Liver Cancer 2013;2:367-383肝脏结节的主要病理特征 血供Normal PVArterial supplyPortal supplyRN low-DN high-DN EHCC wd-HCC md/pd-HCCClassicNormal HAAbnormal HALoss of visualization of portal tracts and development of new arterial vesselsSignificant overlap 原发性肝癌新发和死亡病例 (2012)782000x1033950006Torre LA, et al. CA Cancer J Clin, 2015; Ferlay T, et al. GLOBOCAN 2012中国癌症发病与死亡比较（ 2011-2012）中国肝癌年龄别发病率和死亡率中国肝癌年龄别发病率和死亡率Zuo TT et al. Chin J Cancer 2015; 34: 508-513
